MDCalc

BALL Score for Relapsed/Refractory CLL

Evaluates prognosis of patients with relapsed/refractory chronic lymphocytic leukemia (R/R-CLL) on targeted therapies.

β2-microglobulin

Anemia

Hgb <12 g/dL (<120 g/L) for men; <11 g/dL (<110 g/L) for women

LDH

Last therapy

Time from initiation

Result:

Please fill out required fields.
Advice
  • Results may be helpful for treatment and goals of care discussions between clinicians and patients, guiding decisions regarding management steps, including alternative therapeutic strategies and enrollment in clinical trials.
  • Authors of the derivation study suggest that intermediate- and high-risk individuals may benefit from participation in clinical trials.